Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SOKOLOFF P' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 67 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Beardsley, PM; Sokoloff, P; Balster, RL; Schwartz, JC
      The D3R partial agonist, BP 897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered

      BEHAVIOURAL PHARMACOLOGY
    2. Dziedzicka-Wasylewska, M; Ferrari, F; Johnson, RD; Mierau, J; Rogoz, Z; Skuza, G; Sokoloff, P
      Mechanisms of action of pramipexole: Effects on receptors

      REVIEWS IN CONTEMPORARY PHARMACOTHERAPY
    3. Guillin, O; Diaz, J; Carroll, P; Griffon, N; Schwartz, JC; Sokoloff, P
      BDNF controls dopamine D-3 receptor expression and triggers behavioural sensitization

      NATURE
    4. Scarselli, M; Novi, F; Schallmach, E; Ling, RW; Baragli, A; Colzi, A; Griffon, N; Corsini, GU; Sokoloff, P; Levenson, R; Vogel, Z; Maggio, R
      D-2/D-3 dopamine receptor heterodimers exhibit unique functional properties

      JOURNAL OF BIOLOGICAL CHEMISTRY
    5. Weber, B; Schlicker, E; Sokoloff, P; Stark, H
      Identification of the dopamine autoreceptor in the guinea-pig retina as D-2 receptor using novel subtype-selective antagonists

      BRITISH JOURNAL OF PHARMACOLOGY
    6. Krebs, MO; Guillin, O; Bourdel, MC; Schwartz, JC; Olie, JP; Poirier, MF; Sokoloff, P
      Brain Derived Neurotrophic Factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia

      MOLECULAR PSYCHIATRY
    7. Lammers, CH; Diaz, J; Schwartz, JC; Sokoloff, P
      Selective increase of dopamine D-3 receptor gene expression as a common effect of chronic antidepressant treatments

      MOLECULAR PSYCHIATRY
    8. Perachon, S; Betancur, C; Pilon, C; Rostene, W; Schwartz, JC; Sokoloff, P
      Role of dopamine D-3 receptors in thermoregulation: a reappraisal

      NEUROREPORT
    9. Bordet, R; Ridray, S; Schwartz, JC; Sokoloff, P
      Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats

      EUROPEAN JOURNAL OF NEUROSCIENCE
    10. Le Foll, B; Schwartz, JC; Sokoloff, P
      Dopamine D-3 receptor agents as potential new medications for drug addiction

      EUROPEAN PSYCHIATRY
    11. Sokoloff, P
      The father of dopamine

      M S-MEDECINE SCIENCES
    12. Diaz, J; Pilon, C; Le Foll, B; Gros, C; Triller, A; Schwartz, JC; Sokoloff, P
      Dopamine D-3 receptors expressed by all mesencephalic dopamine neurons

      JOURNAL OF NEUROSCIENCE
    13. Schwartz, JC; Diaz, J; Pilon, C; Sokoloff, P
      Possible implications of the dopamine D-3 receptor in schizophrenia and inantipsychotic drug actions

      BRAIN RESEARCH REVIEWS
    14. Allard, J; Barron, S; Trottier, S; Cervera, P; Daumas-Duport, C; Leguern, E; Brice, A; Schwartz, JC; Sokoloff, P
      Edg-2 in myelin-forming cells: Isoforms, genomic mapping, and exclusion inCharcot-Marie-Tooth disease

      GLIA
    15. Sokoloff, P; Schwartz, JC
      A new therapeutic weapon against drug addiction

      M S-MEDECINE SCIENCES
    16. Matzanke, N; Lowe, W; Perachon, S; Sokoloff, P; Schwartz, JC; Stark, H
      Heterocyclic congeners of PD 128,907 with a partially hydrogenated benzomorpholine moiety as potential dopamine D-3-receptor ligands

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    17. Pilla, M; Perachon, S; Sautel, F; Garrido, F; Mann, A; Wermuth, CG; Schwartz, JC; Everitt, BJ; Sokoloff, P
      Selective inhibition of cocaine-seeking behaviour by a partial dopamine D-3 receptor agonist (vol 400, pg 371, 1999)

      NATURE
    18. Pilla, M; Perachon, S; Sautel, F; Garrido, F; Mann, A; Wermuth, CG; Schwartz, JC; Everitt, BJ; Sokoloff, P
      Selective inhibition of cocaine-seeking behaviour by a partial dopamine D-3 receptor agonist

      NATURE
    19. Perachon, S; Schwartz, JC; Sokoloff, P
      Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D-1, D-2 and D-3 receptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    20. DUAUX E; GORWOOD P; GRIFFON N; BOURDEL MC; SAUTEL F; SOKOLOFF P; SCHWARTZ JC; ADES J; LOO H; POIRIER MF
      HOMOZYGOSITY AT THE DOPAMINE D-3 RECEPTOR GENE IS ASSOCIATED WITH OPIATE DEPENDENCE

      Molecular psychiatry
    21. KREBS MO; SAUTEL F; BOURDEL MC; SOKOLOFF P; SCHWARTZ JC; OLIE JP; LOO H; POIRIER MF
      DOPAMINE D-3 RECEPTOR GENE VARIANTS AND SUBSTANCE-ABUSE IN SCHIZOPHRENIA

      Molecular psychiatry
    22. RIDRAY S; GRIFFON N; MIGNON V; SOUIL E; CARBONI S; DIAZ J; SCHWARTZ JC; SOKOLOFF P
      COEXPRESSION OF DOPAMINE D-1 AND D-3 RECEPTORS IN ISLANDS OF CALLEJA AND SHELL OF NUCLEUS-ACCUMBENS OF THE RAT - OPPOSITE AND SYNERGISTIC FUNCTIONAL INTERACTIONS

      European journal of neuroscience
    23. ALLARD J; BARRON S; DIAZ J; LUBETZKI C; ZALC B; SCHWARTZ JC; SOKOLOFF P
      A RAT G-PROTEIN-COUPLED RECEPTOR SELECTIVELY EXPRESSED IN MYELIN-FORMING CELLS

      European journal of neuroscience
    24. SCHWARTZ JC; DIAZ J; BORDET R; GRIFFON N; PERACHON S; PILON C; RIDRAY S; SOKOLOFF P
      FUNCTIONAL IMPLICATIONS OF MULTIPLE DOPAMINE-RECEPTOR SUBTYPES - THE D-1 D-3 RECEPTOR COEXISTENCE/

      Brain research reviews
    25. KREBS MO; GUILLIN O; SOKOLOFF P; BOURDEL MC; SCHWARTZ JC; OLIE JP; LOO H; POIRIER MF
      ASSOCIATION STUDY OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) POLYMORPHISM IN SCHIZOPHRENIA

      American journal of medical genetics
    26. DUBERTRET C; GORWOOD P; ADES J; FEINGOLD J; SCHWARTZ JC; SOKOLOFF P
      METAANALYSIS OF DRD3 GENE AND SCHIZOPHRENIA - ETHNIC HETEROGENEITY AND SIGNIFICANT ASSOCIATION IN CAUCASIANS

      American journal of medical genetics
    27. PERACHON S; SCHWARTZ JC; SOKOLOFF P
      BINDING AND FUNCTIONAL POTENCIES OF BROMOCRIPTINE, PRAMIPEXOLE, PERGOLIDE AND ROPINIROLE AT D-1, D-2 AND D-3 RECEPTORS

      Neurology
    28. SCHWARTZ JC; DIAZ J; BORDET R; GRIFFON N; PERACHON S; PILON C; RIDRAY S; SOKOLOFF P
      THE D-3 RECEPTOR AND ITS LIGANDS

      Naunyn-Schmiedeberg's archives of pharmacology
    29. GROSS G; BIALOJAN S; DRESCHER K; FREEMAN AS; GARCIALADONA FJ; HOGER T; NEEDHAM P; TESCHENDORF HJ; TREIBER HJ; TRAUT M; SOKOLOFF P; STARCK D; UNGER L; WICKE K
      PHARMACOLOGICAL CHARACTERIZATION OF NOVEL D3 RECEPTOR ANTAGONISTS

      Naunyn-Schmiedeberg's archives of pharmacology
    30. SUZUKI M; HURD YL; SOKOLOFF P; SCHWARTZ JC; SEDVALL G
      D-3 DOPAMINE-RECEPTOR MESSENGER-RNA IS WIDELY EXPRESSED IN THE HUMAN BRAIN

      Brain research
    31. CAINE SB; KOOB GF; PARSONS LH; EVERITT BJ; SCHWARTZ JC; SOKOLOFF P
      D-3 RECEPTOR TEST IN-VITRO PREDICTS DECREASED COCAINE SELF-ADMINISTRATION IN RATS

      NeuroReport
    32. DIAZ R; SOKOLOFF P; FUXE K
      CODISTRIBUTION OF THE DOPAMINE D-3 RECEPTOR AND GLUCOCORTICOID RECEPTOR MESSENGER-RNAS DURING STRIATAL PRENATAL DEVELOPMENT IN THE RAT

      Neuroscience letters
    33. DIAZ J; RIDRAY S; MIGNON V; GRIFFON N; SCHWARTZ JC; SOKOLOFF P
      SELECTIVE EXPRESSION OF DOPAMINE D-3 RECEPTOR MESSENGER-RNA IN PROLIFERATIVE ZONES DURING EMBRYONIC-DEVELOPMENT OF THE RAT-BRAIN

      The Journal of neuroscience
    34. KREBS MO; SAUTEL F; BOURDEL MC; SOKOLOFF P; SCHWARTZ JC; OLIE JP; LOO H; POIRIER MF
      DOPAMINE D3 RECEPTOR GENE VARIANTS AND PHARMACOSENSITIVE SCHIZOPHRENIC-PATIENTS

      American journal of medical genetics
    35. BORDET R; RIDRAY S; CARBON S; DIAZ J; SOKOLOFF P; SCHWARTZ JC
      INDUCTION OF DOPAMINE D-3 RECEPTOR EXPRESSION AS A MECHANISM OF BEHAVIORAL SENSITIZATION TO LEVODOPA

      Proceedings of the National Academy of Sciences of the United Statesof America
    36. GRIFFON N; PILON C; SAUTEL F; SCHWARTZ JC; SOKOLOFF P
      2 INTRACELLULAR SIGNALING PATHWAYS FOR THE DOPAMINE D-3-RECEPTOR - OPPOSITE AND SYNERGISTIC INTERACTIONS WITH CYCLIC-AMP

      Journal of neurochemistry
    37. GRIFFON N; PILON C; SAUTEL F; SCHWARTZ JC; SOKOLOFF P
      ANTIPSYCHOTICS WITH INVERSE AGONIST ACTIVITY AT THE DOPAMINE D-3 RECEPTOR

      Journal of neural transmission
    38. GRIFFON N; SAUTEL F; PILON C; LEVESQUE D; SOKOLOFF P; SCHWARTZ JC; DIAZ J; SIMON P; COSTENTIN J; MANN A; WERMUTH CG
      FUNCTIONAL MODELS FOR THE DOPAMINE D-3 RECEPTOR

      Biochemical Society transactions
    39. GRIFFON N; CROCQ MA; PILON C; MARTRES MP; MAYEROVA A; UYANIK G; BURGERT E; DUVAL F; MACHER JP; JAVOYAGID F; TAMMINGA CA; SCHWARTZ JC; SOKOLOFF P
      DOPAMINE D-3 RECEPTOR GENE - ORGANIZATION, TRANSCRIPT VARIANTS, AND POLYMORPHISM ASSOCIATED WITH SCHIZOPHRENIA

      American journal of medical genetics
    40. PARSONS LH; CAINE SB; SOKOLOFF P; SCHWARTZ JC; KOOB GF; WEISS F
      NEUROCHEMICAL EVIDENCE THAT POSTSYNAPTIC NUCLEUS-ACCUMBENS D-3 RECEPTOR STIMULATION ENHANCES COCAINE REINFORCEMENT

      Journal of neurochemistry
    41. SCHWARTZ JC; PARSONS LH; CAINE SB; LEVESQUE D; DIAZ J; RIDRAY S; SOKOLOFF P; KOOB GF
      THE DOPAMINE D-3 RECEPTOR IN ACCUMBENS - ROLE IN THE ACTIONS OF DRUGSOF ABUSE

      Journal of neurochemistry
    42. JONSSON E; SEDVALL G; BRENE S; GUSTAVSSON JP; GEIJER T; TERENIUS L; CROCQ MA; LANNFELT L; TYLEC A; SOKOLOFF P; SCHWARTZ JC; WIESEL FA
      DOPAMINE-RELATED GENES AND THEIR RELATIONSHIPS TO MONOAMINE METABOLITES IN CSF

      Biological psychiatry
    43. HALL H; HALLDIN C; DIJKSTRA D; WIKSTROM H; WISE LD; PUGSLEY TA; SOKOLOFF P; PAULI S; FARDE L; SEDVALL G
      AUTORADIOGRAPHIC LOCALIZATION OF D-3-DOPAMINE RECEPTORS IN THE HUMAN BRAIN USING THE SELECTIVE D-3-DOPAMINE RECEPTOR AGONIST (-[H-3]PD-128907())

      Psychopharmacology
    44. SAUTEL F; GRIFFON N; LEVESQUE D; PILON C; SCHWARTZ JC; SOKOLOFF P
      A FUNCTIONAL TEST IDENTIFIES DOPAMINE AGONISTS SELECTIVE FOR D3 VERSUS D2 RECEPTORS

      NeuroReport
    45. GRIFFON N; SOKOLOFF P; DIAZ J; LEVESQUE D; SAUTEL F; SCHWARTZ JC; SIMON P; COSTENTIN J; GARRIDO F; MANN A; WERMUTH C
      THE DOPAMINE D-3 RECEPTOR AND SCHIZOPHRENIA - PHARMACOLOGICAL, ANATOMICAL AND GENETIC APPROACHES

      European neuropsychopharmacology
    46. CROCQ MA; DUVAL F; MAYEROVA A; SOKOLOFF P; MOKRANI MC; MACHER JP
      CLINICAL AND FUNCTIONAL CORRELATES OF A DOPAMINE D3 RECEPTOR POLYMORPHISM

      Human psychopharmacology
    47. GRIFFON N; DIAZ J; LEVESQUE D; SAUTEL F; SCHWARTZ JC; SOKOLOFF P; SIMON P; COSTENTIN J; GARRIDO F; MANN A; WERMUTH C
      LOCALIZATION, REGULATION, AND ROLE OF THE DOPAMINE D-3 RECEPTOR ARE DISTINCT FROM THOSE OF THE D-2 RECEPTOR

      Clinical neuropharmacology
    48. MEI YA; GRIFFON N; BUQUET C; MARTRES MP; VAUDRY H; SCHWARTZ JC; SOKOLOFF P; CAZIN L
      ACTIVATION OF DOPAMINE D-4 RECEPTOR INHIBITS AN L-TYPE CALCIUM CURRENT IN CEREBELLAR GRANULE CELLS

      Neuroscience
    49. DIAZ J; LEVESQUE D; LAMMERS CH; GRIFFON N; MARTRES MP; SCHWARTZ JC; SOKOLOFF P
      PHENOTYPICAL CHARACTERIZATION OF NEURONS EXPRESSING THE DOPAMINE D-3 RECEPTOR IN THE RAT-BRAIN

      Neuroscience
    50. SCHWARTZ JC; GRIFFON N; DIAZ J; LEVESQUE D; SAUTEL F; SOKOLOFF P; SIMON P; COSTENTIN J; GARRIDO F; MANN A; WERMUTH C
      THE D-3 RECEPTOR AND ITS RELEVANCE IN PSYCHIATRY

      International clinical psychopharmacology
    51. GORWOOD P; MARTRES MP; ADES J; SOKOLOFF P; NOBLE EP; GEIJER T; BLUM K; NEIMAN J; JONSSON E; FEINGOLD J; SCHWARTZ JC
      LACK OF ASSOCIATION BETWEEN ALCOHOL-DEPENDENCE AND D3 DOPAMINE-RECEPTOR GENE IN 3 INDEPENDENT SAMPLES

      American journal of medical genetics
    52. LEVESQUE D; MARTRES MP; DIAZ J; GRIFFON N; LAMMERS CH; SOKOLOFF P; SCHWARTZ JC
      A PARADOXICAL REGULATION OF THE DOPAMINE D-3 RECEPTOR EXPRESSION SUGGESTS THE INVOLVEMENT OF AN ANTEROGRADE FACTOR FROM DOPAMINE NEURONS

      Proceedings of the National Academy of Sciences of the United Statesof America
    53. SAUTEL F; GRIFFON N; SOKOLOFF P; SCHWARTZ JC; LAUNAY C; SIMON P; COSTENTIN J; SCHOENFELDER A; GARRIDO F; MANN A; WERMUTH CG
      NAFADOTRIDE, A POTENT PREFERENTIAL DOPAMINE D-3 RECEPTOR ANTAGONIST, ACTIVATES LOCOMOTION IN RODENTS

      The Journal of pharmacology and experimental therapeutics
    54. GRIFFON N; PILON C; SCHWARTZ JC; SOKOLOFF P
      THE PREFERENTIAL DOPAMINE D-3 RECEPTOR-LIGAND, (-UH 232, IS A PARTIALAGONIST())

      European journal of pharmacology
    55. SOKOLOFF P; SCHWARTZ JC
      NOVEL DOPAMINE-RECEPTORS HALF A DECADE LATER

      Trends in pharmacological sciences
    56. SCHWARTZ JC; SOKOLOFF P
      FUNCTIONAL RELEVANCE OF DOPAMINE-RECEPTORS - REPLY

      Trends in pharmacological sciences
    57. DIAZ J; LEVESQUE D; GRIFFON N; LAMMERS CH; MARTRES MP; SOKOLOFF P; SCHWARTZ JC
      OPPOSING ROLES FOR DOPAMINE D-2 AND D-3 RECEPTORS ON NEUROTENSIN MESSENGER-RNA EXPRESSION IN NUCLEUS-ACCUMBENS

      European journal of neuroscience
    58. PILON C; LEVESQUE D; DIMITRIADOU V; GRIFFON N; MARTRES MP; SCHWARTZ JC; SOKOLOFF P
      FUNCTIONAL COUPLING OF THE HUMAN DOPAMINE-D-3 RECEPTOR IN A TRANSFECTED NG-108-15 NEUROBLASTOMA-GLIOMA HYBRID CELL-LINE

      European journal of pharmacology. Molecular pharmacology section
    59. DUVAL F; CROCQ MA; MAYEROVA A; SOKOLOFF P; NATT E; LANNFELT L; MOKRANI MC; BAILEY P; SCHWARTZ JC; MACHER JP
      DOPAMINE D3 RECEPTOR POLYMORPHISM AND RESPONSE TO APOMORPHINE CHALLENGE

      Biological psychiatry
    60. GRIFFON N; MIGNON V; FACCHINETTI P; DIAZ J; SCHWARTZ JC; SOKOLOFF P
      MOLECULAR-CLONING AND CHARACTERIZATION OF THE RAT 5TH MELANOCORTIN RECEPTOR

      Biochemical and biophysical research communications
    61. SABATE O; CAMPION D; DAMATO T; MARTRES MP; SOKOLOFF P; GIROS B; LEBOYER M; JAY M; GUEDJ F; THIBAUT F; DOLLFUS S; PRETERRE P; PETIT M; BABRON MC; WAKSMAN G; MALLET J; SCHWARTZ JC
      FAILURE TO FIND EVIDENCE FOR LINKAGE OR ASSOCIATION BETWEEN THE DOPAMINE D-3 RECEPTOR GENE AND SCHIZOPHRENIA

      The American journal of psychiatry
    62. SCHWARTZ JC; LEVESQUE D; MARTRES MP; SOKOLOFF P
      DOPAMINE-D(3) RECEPTOR - BASIC AND CLINICAL ASPECTS

      Clinical neuropharmacology
    63. DIMARZO V; VIAL D; SOKOLOFF P; SCHWARTZ JC; PIOMELLI D
      SELECTION OF ALTERNATIVE-G(I)-MEDIATED SIGNALING PATHWAYS AT THE DOPAMINE-D(2) RECEPTOR BY PROTEIN-KINASE-C

      The Journal of neuroscience
    64. RIETSCHEL M; NOTHEN MM; LANNFELT L; SOKOLOFF P; SCHWARTZ JC; LANCZIK M; FRITZE J; CICHON S; FIMMERS R; KORNER J; MOLLER HJ; PROPPING P
      A SERINE TO GLYCINE SUBSTITUTION AT POSITION-9 IN THE EXTRACELLULAR N-TERMINAL PART OF THE DOPAMINE-D3 RECEPTOR PROTEIN - NO ROLE IN THE GENETIC PREDISPOSITION TO BIPOLAR AFFECTIVE-DISORDER

      Psychiatry research
    65. MITCHELL P; WATERS B; VIVERO C; FIE L; DONALD J; TULLY M; CAMPEDELLI K; LANNFELT L; SOKOLOFF P; SHINE J; SELBIE L
      EXCLUSION OF CLOSE LINKAGE OF BIPOLAR DISORDER TO THE DOPAMINE-D(3) RECEPTOR GENE IN 9 AUSTRALIAN PEDIGREES

      Journal of affective disorders
    66. YANG L; LI T; WIESE C; LANNFELT L; SOKOLOFF P; XU CT; ZENG Z; SCHWARTZ JC; LIU XH; MOISES HW
      NO ASSOCIATION BETWEEN SCHIZOPHRENIA AND HOMOZYGOSITY AT THE D(3)-DOPAMINE RECEPTOR GENE

      American journal of medical genetics
    67. JONSSON E; LANNFELT L; SOKOLOFF P; SCHWARTZ JC; SEDVALL G
      LACK OF ASSOCIATION BETWEEN SCHIZOPHRENIA AND ALLELES IN THE DOPAMINE-D3 RECEPTOR GENE

      Acta psychiatrica Scandinavica


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/08/20 alle ore 01:55:24